Volume : 08, Issue : 05, May – 2021

Title:

30.TO ESTABLISH A RELATIONSHIP BETWEEN SERUM FERRITIN LEVELS AND TREATMENT OUTCOMES IN COVID-19 PATIENTS

Authors :

Syed Yasir Hussain and Ihsanullah Khan

Abstract :

Background: COVID-19, a pandemic affecting the entire world and causing significant morbidity and mortality, requires immediate evaluation and identification of reliable predictors of disease severity and outcome. COVID-19-associated fatalities are accompanied by cytokine storm syndrome. Serum ferritin is used to determine the cytokine storm.
Aims and Objective: The purpose of this study was to determine the role of serum ferritin in determining the severity and outcome of COVID-19.
Materials and Methods: From March to May 2020, a single-center, cross-sectional, observational study was conducted among SARS-CoV-2 infected patients. A real-time polymerase chain reaction was used to confirm the diagnosis (RT-PCR). The serum ferritin levels of COVID-19 positive patients were compared to their treatment outcomes.
Results: The study enrolled a total of 1977 COVID-19 patients. The mean age of the subjects was 43.8915.58 years, with a male predominance of 61.56 percent. The mean serum ferritin levels were 1225.6 2502.91 ng/ml in recovered patients and 285.71 391.99 ng/ml in expired patients, respectively.
Conclusion: Serum ferritin levels were significantly increased in COVID-19 patients who died compared to those who recovered completely, establishing it as a useful marker for assessing the severity of the infection.
Key words: cytokine storm, Serum ferritin, COVID-19

Cite This Article:

Please cite this article in press Syed Yasir Hussain and Ihsanullah Khan., To Establish A Relationship Between Serum Ferritin Levels And Treatment Outcomes In Covid-19 Patients .., Indo Am. J. P. Sci, 2021; 08(05).

Number of Downloads : 10

References:

1. Pneumonia of unknown cause – China [Internet]. World Health Organization. 2021 [cited 2021 Jan 22]. Available from: https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkowncause-china/en/
2. COVID-19 Mortality Trends and Reporting [Internet]. Economic and Political Weekly. 2021 [cited 2021 Jan 22]. Available from: https://www.epw.in/journal/2020/37/commentary/covid-19- mortality-trends-and-reporting.html
3. MoHFW. [Home] [Internet]. Mohfw.gov.in. 2021 [cited 2021 Jan 22]. Available from: https://www.mohfw.gov.in
4. Lu R, Qin J, Wu Y, Wang J, Huang S and Tian L. Epidemiological and clinical characteristics of COVID-19 patients in Nantong, China. J Infect Dev Ctries. 2020;14(05):440-446. https://doi.org/10.3855/jidc.12678
5. Saluja M, Pillai D, Jeliya S, Bauddh N and Chandel R. COVID 19- Clinical Profile, Radiological Presentation, Prognostic Predictors, Complications and Outcome: A Perspective from the Indian Subcontinent. J Assoc Physicians India. 2020;68(7):13-18.
6. Romero Starke K, Petereit-Haack G, Schubert M, Kämpf D, Schliebner A, Hegewald J, et al. The Age-Related Risk of Severe Outcomes Due to COVID-19 Infection: A Rapid Review, MetaAnalysis, and Meta-Regression. Int J Environ Res Public Health. 2020; 17(16): 5974. https://doi.org/10.3390/ijerph17165974
7. Bonanad C, García-Blas S, Tarazona-Santabalbina F, Sanchis J, Bertomeu-González V, Fácila L, et al. The Effect of age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects. Journal of the American Medical Directors Association. 2020;21(7):915-918. https://doi.org/10.1016/j.jamda.2020.05.045
8. Zhang B, Zhou X, Qiu Y, Song Y, Feng F, Feng J, et al. Clinical characteristics of 82 cases of death from COVID-19. PLoS ONE. 2020;15(7):e0235458. https://doi.org/10.1371/journal.pone.0235458
9. Gupta N, Agrawal S, Ish P, Mishra S, Gaind R, Usha G, et al. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Archives for Chest Disease. 2020;90(1). https://doi.org/10.4081/monaldi.2020.1294
10. Burugu H, Kandi V, Kutikuppala LVS and Suvvari TK. Activities of Serum Ferritin and Treatment Outcomes Among COVID-19 Patients Treated with Vitamin C and Dexamethasone: An Uncontrolled Single-Center Observational Study. Cureus. 2020;12(11): e11442. https://doi.org/10.7759/cureus.11442
11. Singh AK and Misra A. Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India. Diabetes Metab Syndr. 2020;14(6):1625-1630. https://doi.org/10.1016/j.dsx.2020.08.032